plerixafor has been researched along with AL Amyloidosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buadi, FK; Dingli, D; Dispenzieri, A; Fonder, AL; Gertz, MA; Go, RS; Gonsalves, WI; Hayman, SR; Hobbs, MA; Hogan, WJ; Hwa, YL; Kapoor, P; Kumar, SK; Kyle, RA; Lacy, MQ; Leung, N; Lust, JA; Rajkumar, SV; Russell, SJ; Sidana, S; Tandon, N; Zeldenrust, SR | 1 |
| Andrea, N; Lee, SY; Mark Sloan, J; Quillen, K; Sanchorawala, V; Seldin, DC | 1 |
| Chaulagain, C; Comenzo, RL; Kaul, E; Shah, G | 1 |
3 other study(ies) available for plerixafor and AL Amyloidosis
| Article | Year |
|---|---|
Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis.
Topics: Aged; Algorithms; Antigens, CD34; Benzylamines; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Melphalan; Middle Aged; Retrospective Studies | 2018 |
Plerixafor-augmented peripheral blood stem cell mobilization in AL amyloidosis with cardiac involvement: a case series.
Topics: Amyloidosis; Antineoplastic Agents, Alkylating; Benzylamines; Cyclams; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Heart Failure; Heart Transplantation; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Immunoglobulin Light-chain Amyloidosis; Male; Melphalan; Middle Aged; Remission Induction; Transplantation, Autologous | 2014 |
Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis.
Topics: Aged; Amyloidosis; Benzylamines; Cyclams; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Immunoglobulin Light-chain Amyloidosis; Middle Aged | 2014 |